over the counter

Judge Denies FDA Bid to Stay 'Morning-After' Pill Ruling

A federal judge Friday declined to temporarily halt a court order directing the FDA to make emergency contraception available over-the-counter to girls of all ages.

The Best Deals on Over-the-Counter Medications -- Savings Experiment

Millions of Rolaids Recalled After Bits of Metal, Wood Are Found

CVS settles with Pennsylvania over selling expired goods

Johnson & Johnson Earnings Up, but Recalls Cut Guidance

Johnson & Johnson's earnings for the second quarter of 2010 rose 5.4% to $3.4 billion, or $1.23 per share, from $3.2 billion or $1.15 per share, the company announced Tuesday morning. Adjusted earnings, which exclude litigation costs, were $1.21 per share.

Johnson & Johnson expands Tylenol, Benadryl recall

Walgreens halts genetic test sales on FDA concerns

Sanofi-Aventis Buys Chattem, a Leader in Over-the-Counter Sales

Sanofi-Aventis announced Monday it will acquire Chattem Inc. for about $1.9 billion -- paying $93.50 per share, a 34% premium over Chattem's closing price Friday. The deal will create the world's fifth-largest consumer health-care company by revenues and helps Sanofi diversify into over-the-counter and consumer brands: a strategy used by Johnson & Johnson, and one many pharmas seek to adopt before the coming patent cliff.

SEC chief calls for stronger rules on derivatives trading